At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Efficacy of AlphaWave® L-Theanine on Adults Who Experience Moderate Stress on a Regular Basis
In Brief
A Phase 2 clinical trial evaluating AlphaWave® L-Theanine and Placebo for Stress. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the efficacy of AlphaWave® L-Theanine on stress among adults who experience moderate stress on a regular basis. The difference in change in stress as assessed by salivary cortisol from baseline at Days 14 and 28 will be compared between AlphaWave® L-Theanine and Placebo groups. Additionally, the safety and tolerability of AlphaWave® L-Theanine, as compared to placebo, will be measured by the occurrence of an/or changes in pre-emergent and post-emergent adverse events (AEs).
Study Details
Timeline
Interventions
One capsule of AlphaWave® L-Theanine will be taken twice daily for 28 days.
One capsule of Placebo will be taken twice daily for 28 days.